| 标题 |
114P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Long-term efficacy and safety analysis of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:C. Jackisch; S-A. Im; A. Mattar; R. Colomer Bosch; D. Stroyakovskiy; et al 出版日期:2024-05-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)